个性化文献订阅>期刊> ACS Medicinal Chemistry Letters
 

Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic Acids

  作者 CROSIGNANI STEFANO; JORANDLEBRUN CATHERINE; CAMPBELL GORDON; PRETRE ADELINE; GRIPPIVALLOTTON TANIA; QUATTROPANI ANNA; BOUSCARYDESFORGES GWENAELLE; BOMBRUN AGNES; MISSOTTEN MARC; HUMBERT YVES; FREMAUX CHRISTELE; PAQUET MIKAEL; EL HARKANI KAMEL; BRADSHAW CHARLES G; CLEVA CHRISTOPHE; ABLA NADA; DAFF HAMINA; SCHOTT OLIVIER; PITTET PIERREANDRE; ARRIGHI JEANFRANCOIS; GAUDET MARILENE; JOHNSON ZOE  
  选自 期刊  ACS Medicinal Chemistry Letters;  卷期  2011年2-12;  页码  938-942  
  关联知识点  
 

[摘要]Antagonism of the CRTH2 receptor represents a very attractive target for a variety of allergic diseases. Most CRTH2 antagonists known to date possess a carboxylic acid moiety, which is essential for binding. However, potential acid metabolites O-acyl glucuronides might be linked to idiosynchratic toxicity in humans. In this communication, we describe a new series of compounds that lack the carboxylic acid moiety. Compounds with high affinity (K(i) < 10 nM) for the receptor have been identified. Subsequent optimization succeeded in reducing the high metabolic clearance of the first compounds in human and rat liver microsomes. At the same time, inhibition of the CYP isoforms was optimized, giving rise to stable compounds with an acceptable CYP inhibition profile (IC(50) CYP2C9 and 2C19 > 1 mu M). Taken together, these data show that compounds devoid of carboxylic acid groups could represent an interesting alternative to current CRTH2 antagonists in development.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内